Abbott (ABT) Has a Multi-Platform Device-and-Diagnostics Engine Bigger Than the Libre Narrative

[ad_1] Abbott Laboratories (ABT) is often reduced to a FreeStyle Libre story, but the latest quarter shows why that framing is too narrow. In Q1 2026, reported on April 16, 2026, total sales rose 7.8% year over year to $11.16…








